FeesSafety
Pluang+

Tandem Diabetes Care holds steady despite near-term challenges and growth uncertainties until 2027.

Market News
16 Nov 2026, 15:15 WIB
Seeking Alpha
View Source
Neutral
Tandem Diabetes Care holds steady despite near-term challenges and growth uncertainties until 2027.

Tandem Diabetes Care reported a 13.8% revenue increase in Q3, but growth was mainly driven by international one-offs while U.S. growth was only 9%, signaling underlying weakness. The company’s PayGo program doubled patient revenue but faces delayed profitability and adoption risks. Its new FDA-cleared Mobi Tubeless device could boost growth from 2028, though patient uptake remains uncertain. Overall, the stock is rated Hold due to short-term underperformance offset by potential long-term upside after 2027.

Tandem Diabetes Care's Q3 revenue rose 13.8%, supported by international one-offs and a 9% U.S. growth. For readers following the health sector, here is Pluang's market snapshot as of Nov 16, 2026 19:13 WIB: Among 150 priced health-sector US stocks, 67 advanced and 61 declined. Notable movers include TNGX at USD 24.64 with a -3.37% change and a typical hold time of 5 days, GH at USD 147.01 down 3.18% with a 10-day hold, and BNGO at USD 1.03 up 3.00% with a 52-day hold.

More News

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
35 minutes ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
35 minutes ago
Saputo renews share buyback program to repurchase up to 10% of public shares through Nov 2027.

Saputo renews share buyback program to repurchase up to 10% of public shares through Nov 2027.

Saputo Inc. announced the renewal of its normal course issuer bid, allowing it to repurchase up to 22.5 million ordinary shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's ongoing c...

Company Fundamentals
Bullish
35 minutes ago
Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo plc and Curio Legacy Ventures announced a collaboration to supply recycled nuclear materials for mixed-oxide (MOX) fuel production at Newcleo's planned US fuel manufacturing facility. This partnership combines Curio's NuCycle recycling techno...

Market News
Bullish
1 hour ago
Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics announced a 38% year-over-year revenue increase for Q3 2026, driven by its IC Drone insulator-cleaning activities. The company expanded its IC Drone platform into Greece through a strategic collaboration with CRONOS, identifying potenti...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App